Systematic Review of Incidence and Complications of Herpes Zoster Towards a Global Perspective

Review

. 2014 Jun ten;4(half-dozen):e004833.

doi: 10.1136/bmjopen-2014-004833.

Systematic review of incidence and complications of herpes zoster: towards a global perspective

Affiliations

• PMID: 24916088
• PMCID: PMC4067812
• DOI: 10.1136/bmjopen-2014-004833

Free PMC article

Review

Systematic review of incidence and complications of herpes zoster: towards a global perspective

Kosuke Kawai  et al. BMJ Open. 2014 .

Gratuitous PMC article

Abstract

Objective: The objective of this report was to characterise the incidence rates of herpes zoster (HZ), also known as shingles, and risk of complications across the world.

Pattern: We systematically reviewed studies examining the incidence rates of HZ, temporal trends of HZ, the take chances of complications including postherpetic neuralgia (PHN) and HZ-associated hospitalisation and mortality rates in the general population. The literature search was conducted using PubMed, EMBASE and the WHO library up to December 2013.

Results: We included 130 studies conducted in 26 countries. The incidence rate of HZ ranged betwixt 3 and five/1000 person-years in North America, Europe and Asia-Pacific, based on studies using prospective surveillance, electronic medical record data or authoritative data with medical record review. A temporal increase in the incidence of HZ was reported in the by several decades across seven countries, frequently occurring earlier the introduction of varicella vaccination programmes. The adventure of developing PHN varied from v% to more xxx%, depending on the type of study design, age distribution of study populations and definition. More xxx% of patients with PHN experienced persistent pain for more than than ane yr. The risk of recurrence of HZ ranged from 1% to half-dozen%, with long-term follow-up studies showing higher take a chance (v-6%). Hospitalisation rates ranged from 2 to 25/100 000 person-years, with higher rates among elderly populations.

Conclusions: HZ is a pregnant global health burden that is expected to increase every bit the population ages. Time to come research with rigorous methods is of import.

Keywords: EPIDEMIOLOGY; VIROLOGY.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted nether a licence) please become to http://group.bmj.com/group/rights-licensing/permissions.

Figures

Figure 1

Written report selection.

Effigy ii

Age-specific incidence charge per unit of herpes zoster in North America, Europe and Asia-Pacific.

Similar articles

• A population-based study of the incidence and complication rates of herpes zoster earlier zoster vaccine introduction.

  Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. Yawn BP, et al. Mayo Clin Proc. 2007 Nov;82(11):1341-9. doi: 10.4065/82.11.1341. Mayo Clin Proc. 2007. PMID: 17976353

• Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.

  Tseng HF, Lewin B, Hales CM, Sy LS, Harpaz R, Bialek Due south, Luo Y, Jacobsen SJ, Reddy G, Huang PY, Zhang J, Anand S, Bauer EM, Chang J, Tartof SY. Tseng HF, et al. J Infect Dis. 2015 October fifteen;212(8):1222-31. doi: 10.1093/infdis/jiv244. Epub 2015 Jun 1. J Infect Dis. 2015. PMID: 26038400 Free PMC article.

• Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.

  Johnson RW. Johnson RW. Aging Clin Exp Res. 2009 Jun;21(iii):236-43. doi: 10.1007/BF03324909. Aging Clin Exp Res. 2009. PMID: 19571648 Review.

• Incidence and costs of herpes zoster and postherpetic neuralgia in German language adults anile ≥l years: A prospective study.

  Schmidt-Ott R, Schutter U, Simon J, Nautrup BP, von Krempelhuber A, Gopala K, Anastassopoulou A, Guignard A, Curran D, Matthews South, Espié E. Schmidt-Ott R, et al. J Infect. 2018 May;76(5):475-482. doi: x.1016/j.jinf.2018.02.001. Epub 2018 February 8. J Infect. 2018. PMID: 29428228

• A population based study of the epidemiology of Canker Zoster and its complications.

  Weitzman D, Shavit O, Stein M, Cohen R, Chodick Chiliad, Shalev V. Weitzman D, et al. J Infect. 2013 Nov;67(5):463-9. doi: 10.1016/j.jinf.2013.06.016. Epub 2013 Jul 16. J Infect. 2013. PMID: 23872209

Cited by 203 manufactures

• Increased Risk of Herpes Zoster in Adults ≥50 Years One-time Diagnosed With COVID-19 in the Usa.

  Bhavsar A, Lonnet M, Wang C, Chatzikonstantinidou One thousand, Parikh R, Brabant Y, Servotte N, Shi Grand, Widenmaier R, Aris E. Bhavsar A, et al. Open Forum Infect Dis. 2022 Mar ix;nine(5):ofac118. doi: 10.1093/ofid/ofac118. eCollection 2022 May. Open up Forum Infect Dis. 2022. PMID: 35392454 Free PMC article.

• The effectiveness of repetitive paravertebral block with ropivacaine and dexmedetomidine for the prevention of postherpetic neuralgia in patients with acute herpes zoster.

  Yang F, Liao P, You Y, Liang Y, Hu Y. Yang F, et al. Postepy Dermatol Alergol. 2022 Feb;39(1):116-120. doi: x.5114/ada.2021.106021. Epub 2021 Oct 25. Postepy Dermatol Alergol. 2022. PMID: 35369628 Costless PMC article.

• Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.

  Pan CX, Lee MS, Nambudiri VE. Pan CX, et al. Ther Adv Vaccines Immunother. 2022 Mar 21;10:25151355221084535. doi: x.1177/25151355221084535. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35340552 Gratis PMC commodity. Review.

• Effect of Routine Varicella Immunization on the Epidemiology and Immunogenicity of Varicella and Shingles.

  Otani North, Shima Chiliad, Yamamoto T, Okuno T. Otani N, et al. Viruses. 2022 Mar 12;14(three):588. doi: 10.3390/v14030588. Viruses. 2022. PMID: 35336994 Free PMC article. Review.

• Acupuncture therapies for postherpetic neuralgia: a protocol for a systematic review and Bayesian network meta-analysis.

  Bian Z, Yu J, Tu M, Liao B, Huang J, Izumoji G, Lord's day R, Xu Y, Jiang Y, He X, Fang J. Bian Z, et al. BMJ Open up. 2022 Mar 17;12(3):e056632. doi: 10.1136/bmjopen-2021-056632. BMJ Open. 2022. PMID: 35301212 Complimentary PMC article.

References

1. 1. Cohen JI. Clinical practise: herpes zoster. N Engl J Med 2013;369:255–63 - PMC - PubMed
2. 1. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44(Suppl 1):S1–26 - PubMed
3. 1. Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341–9 - PubMed
4. 1. Hope-Simpson RE. The nature of canker zoster: a long-term written report and a new hypothesis. Proc R Soc Med 1965;58:nine–20 - PMC - PubMed
5. 1. Johnson RW, Bouhassira D, Kassianos G, et al. The impact of canker zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010;eight:37. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more than resources

• Full Text Sources

  • Europe PubMed Primal
  • HighWire
  • PubMed Central

• Other Literature Sources

  • scite Smart Citations

• Medical

  • ClinicalTrials.gov
  • MedlinePlus Wellness Information

• Miscellaneous

  • NCI CPTAC Analysis Portal

daughertyharioned49.blogspot.com

Source: https://pubmed.ncbi.nlm.nih.gov/24916088/

Share this post